'Fat-proof' mice yield new anti-obesity drug target

November 27, 2000

HOUSTON--(Nov. 28, 2000)--Forget the fountain of youth. Scientists at Baylor College of Medicine may have found something even more exciting--the secret to effortless weight loss. The key is outsmarting perilipin, a protein that acts as a "bodyguard" for fat cells.

The Baylor researchers discovered the fat-protecting role of perilipin after breeding laboratory mice to eliminate the gene that codes for the protein. The team's findings appear in the December issue of Nature Genetics.

"Perilipin works by coating the surface of fat storage droplets inside fat cells, protecting them from hormone-sensitive lipase, HSL, a fat-metabolizing enzyme," said Dr. Lawrence Chan, a Baylor professor in the departments of medicine and molecular and cellular biology and lead investigator of the study.

But for perilipin-free mice, fat storage is a losing battle because HSL metabolizes fat as soon as it is made. "This process burns a great deal of energy that would otherwise be deposited as fat," Chan said.

The extra calorie-burning capacity of the perilipin-free mice was reflected in their metabolic rate, which was consistently higher than that of their wild-type cage-mates, said Chan. The mice also had eight percent more muscle and only about half as much body fat--despite consuming 25 percent more food and leading a "couch mouse" existence. And, while both groups of mice had the same number of fat cells, those of the perilipin-free mice were only half as large.

Being perilipin-free also benefited db/db mice, so named because they inherit the db gene that predisposes them to obesity from both parents. The mice, though genetically programmed to be obese, grew up lean after losing the ability to make perilipin.

"These results are very exciting because not only is perilipin active in humans, it is made almost exclusively by fat cells," Chan said.

The latter could be key to the success of new, anti-perilipin drugs designed to fight obesity. According to Chan, drugs that disrupt a very precise target like perilipin in body tissues have potentially fewer side effects than those affecting the brain or multiple organ systems.

Although he believes that perilipin research is very promising, Chan remains cautious. "This is an exciting first step, but it will take time to move perilipin research from experiments in mice to helping humans with weight problems," he said.
-end-


Baylor College of Medicine

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.